|
Volumn 64, Issue 2, 2007, Pages 139-146
|
Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents
|
Author keywords
Antimycobacterial; Pyrazolines
|
Indexed keywords
5 [2 CHLOROPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [2 CHLOROPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [2,6 DICHLOROPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [2,6 DICHLOROPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [3 NITROPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [3 NITROPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [3,4 DIMETHOXYPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [3,4 DIMETHOXYPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [3,4,5 TRIMETHOXYPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [3,4.5 TRIMETHOXYPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [4 CHLOROPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [4 CHLOROPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [4 FLUOROPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [4 METHOXYPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [4 METHOXYPHENYL] 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 [DIMETHYLAMINOPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 [FLUOROPHENYL] 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 FURYL 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 FURYL 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
5 PHENYL 3 (4 HYDROXY 3 METHYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 TOLUIDINOMETHANETHIONE;
5 PHENYL 3 (4 HYDROXY 3 METHYLPHENYL) 4,5 DIHYDRO 1H 1 PYRAZOLYL 2 METHOXYANILINOMETHANETHIONE;
ANTIMYCOBACTERIAL AGENT;
ISONIAZID;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
PYRAZOLE DERIVATIVE;
ANIMAL CELL;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IN VITRO STUDY;
INFRARED SPECTROMETRY;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
STRUCTURE ACTIVITY RELATION;
THIN LAYER CHROMATOGRAPHY;
VERO CELL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG EFFECT;
GENETICS;
IC 50;
IMMUNOLOGY;
METHODOLOGY;
MICROBIOLOGICAL EXAMINATION;
SYNTHESIS;
ANTITUBERCULAR AGENTS;
INHIBITORY CONCENTRATION 50;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
MYCOBACTERIUM TUBERCULOSIS;
PYRAZOLES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 35148893201
PISSN: 00016837
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (16)
|